Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1959 1
1968 1
1970 1
1973 1
1974 1
1975 3
1977 2
1980 2
1981 2
1982 4
1983 2
1984 3
1985 4
1986 4
1987 7
1988 2
1989 6
1990 7
1991 5
1992 5
1993 9
1994 6
1995 7
1996 11
1997 10
1998 10
1999 8
2000 10
2001 9
2002 11
2003 13
2004 11
2005 13
2006 16
2007 12
2008 12
2009 21
2010 36
2011 38
2012 40
2013 43
2014 36
2015 40
2016 38
2017 28
2018 45
2019 42
2020 56
2021 48
2022 46
2023 47
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

763 results

Results by year

Filters applied: . Clear all
Page 1
Current treatment and recent progress in gastric cancer.
Joshi SS, Badgwell BD. Joshi SS, et al. CA Cancer J Clin. 2021 May;71(3):264-279. doi: 10.3322/caac.21657. Epub 2021 Feb 16. CA Cancer J Clin. 2021. PMID: 33592120 Free PMC article. Review.
Biological differences between tumors from Eastern and Western countries add to the complexity of identifying standard-of-care therapy based on international trials. Systemic chemotherapy, radiotherapy, surgery, immunotherapy, and targeted therapy all have pr …
Biological differences between tumors from Eastern and Western countries add to the complexity of identifying standard-of-care the …
Diagnosis and management of choledochal cysts.
Brown ZJ, Baghdadi A, Kamel I, Labiner HE, Hewitt DB, Pawlik TM. Brown ZJ, et al. HPB (Oxford). 2023 Jan;25(1):14-25. doi: 10.1016/j.hpb.2022.09.010. Epub 2022 Oct 5. HPB (Oxford). 2023. PMID: 36257874 Free article. Review.
RESULTS: Classified according to the Todani Classification, CCs are generally believed to arise secondary to reflux of pancreatic enzymes into the biliary tree due to anomalous pancreaticobiliary duct union. ...CONCLUSION: Most CCs should undergo surgical intervention to m …
RESULTS: Classified according to the Todani Classification, CCs are generally believed to arise secondary to reflux of pancreatic enz …
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA, D'Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Farjah F, Gerdes H, Gibson M, Grierson P, Hofstetter WL, Ilson DH, Jalal S, Keswani RN, Kim S, Kleinberg LR, Klempner S, Lacy J, Licciardi F, Ly QP, Matkowskyj KA, McNamara M, Miller A, Mukherjee S, Mulcahy MF, Outlaw D, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian NR, Pluchino LA. Ajani JA, et al. J Natl Compr Canc Netw. 2023 Apr;21(4):393-422. doi: 10.6004/jnccn.2023.0019. J Natl Compr Canc Netw. 2023. PMID: 37015332
Systemic therapy can provide palliation, improved survival, and enhanced quality of life in patients with locally advanced or metastatic disease. ...Palliative management, which may include systemic therapy, chemoradiation, and/or best supportive care, …
Systemic therapy can provide palliation, improved survival, and enhanced quality of life in patients with locally advanced or meta …
Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment.
Taieb J, Svrcek M, Cohen R, Basile D, Tougeron D, Phelip JM. Taieb J, et al. Eur J Cancer. 2022 Nov;175:136-157. doi: 10.1016/j.ejca.2022.07.020. Epub 2022 Sep 14. Eur J Cancer. 2022. PMID: 36115290 Review.
Microsatellite unstable (MSI) colorectal cancers (CRCs) are due to DNA mismatch repair (MMR) deficiency and occurs in15% of non-metastatic diseases and 5% in the metastatic setting. Nearly 30% of MSI CRCs occur in a context of constitutional mutation of the MMR s …
Microsatellite unstable (MSI) colorectal cancers (CRCs) are due to DNA mismatch repair (MMR) deficiency and occurs in15% of non-metastati …
Current opinions on diagnosis and treatment of adenoid cystic carcinoma.
Fang Y, Peng Z, Wang Y, Gao K, Liu Y, Fan R, Zhang H, Xie Z, Jiang W. Fang Y, et al. Oral Oncol. 2022 Jul;130:105945. doi: 10.1016/j.oraloncology.2022.105945. Epub 2022 Jun 2. Oral Oncol. 2022. PMID: 35662026 Review.
Adenoid cystic carcinoma (ACC) is a rare malignant tumor derived mainly from the salivary glands, representing approximately 1% of all headandneck carcinomasand 10% of all salivary gland neoplasms. ...In this review, we aimed toprovideanupdatedinsight intothe unders …
Adenoid cystic carcinoma (ACC) is a rare malignant tumor derived mainly from the salivary glands, representing approximately 1% of al …
AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.
Su GL, Altayar O, O'Shea R, Shah R, Estfan B, Wenzell C, Sultan S, Falck-Ytter Y. Su GL, et al. Gastroenterology. 2022 Mar;162(3):920-934. doi: 10.1053/j.gastro.2021.12.276. Gastroenterology. 2022. PMID: 35210014
RESULTS: The Panel reviewed the evidence, summarized in the Technical Review, for the following medications approved by the US Food and Drug Administration for HCC: first-line therapies: bevacizumab+atezolizumab, sorafenib, and lenvatinib; second-line therapies: cab …
RESULTS: The Panel reviewed the evidence, summarized in the Technical Review, for the following medications approved by the US Food and Drug …
Treatment of gastric adenocarcinoma: A rapidly evolving landscape.
Taieb J, Bennouna J, Penault-Llorca F, Basile D, Samalin E, Zaanan A. Taieb J, et al. Eur J Cancer. 2023 Dec;195:113370. doi: 10.1016/j.ejca.2023.113370. Epub 2023 Oct 17. Eur J Cancer. 2023. PMID: 37948843 Free article. Review.
Gastric adenocarcinoma (GC) and gastroesophageal junction adenocarcinoma represent frequent and severe diseases whose management has radically changed over the last 10 years. With the advent of second- and third-line standard therapies for metastatic GC patients in …
Gastric adenocarcinoma (GC) and gastroesophageal junction adenocarcinoma represent frequent and severe diseases whose management has radical …
Management of immune-related adverse events and kinetics of response with ipilimumab.
Weber JS, Kähler KC, Hauschild A. Weber JS, et al. J Clin Oncol. 2012 Jul 20;30(21):2691-7. doi: 10.1200/JCO.2012.41.6750. Epub 2012 May 21. J Clin Oncol. 2012. PMID: 22614989 Review.
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab and tremelimumab-have been investigated in metastatic melanoma and other cancers and have shown promising results. ...We provide a detailed desc …
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab and tremeli …
ACG clinical guideline: the diagnosis and management of focal liver lesions.
Marrero JA, Ahn J, Rajender Reddy K; Americal College of Gastroenterology. Marrero JA, et al. Am J Gastroenterol. 2014 Sep;109(9):1328-47; quiz 1348. doi: 10.1038/ajg.2014.213. Epub 2014 Aug 19. Am J Gastroenterol. 2014. PMID: 25135008
The increasing and widespread use of imaging studies has led to an increase in detection of incidental FLL. It is important to consider not only malignant liver lesions, but also benign solid and cystic liver lesions such as hemangioma, focal nodular hyperplasia, hepatocel …
The increasing and widespread use of imaging studies has led to an increase in detection of incidental FLL. It is important to consider not …
Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
Miettinen M, Lasota J. Miettinen M, et al. Arch Pathol Lab Med. 2006 Oct;130(10):1466-78. doi: 10.5858/2006-130-1466-GSTROM. Arch Pathol Lab Med. 2006. PMID: 17090188 Free article. Review.
CONCLUSIONS: GISTs usually occur in older adults (median age 55-60 years) and rarely in children in the second decade (<1%) throughout the gastrointestinal tract: 60% in stomach, 35% in small intestine, and less than 5% in rectum, esophagus, omentum, and mesentery; most GISTs …
CONCLUSIONS: GISTs usually occur in older adults (median age 55-60 years) and rarely in children in the second decade (<1%) throughout th …
763 results